| Engineered Adenovirus Selectively Targets Tumor Cells |
|
|
|
|
|
| Monday, 09 June 2003 | ||
NEW YORK (Reuters Health) - A genetically engineered adenovirus vector that selectively replicates in the presence of certain tumor cells appears to be a promising approach to targeted cancer treatment, researchers report in the advance on-line edition of the July issue of Nature Biotechnology.
Please log-in or register in order to submit comments. Powered by AkoComment! |
||
| < Prev | Next > |
|---|
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2008 UroToday ® All Rights Reserved |
